abstract |
The present invention relates to a novel vaccine adjuvant composition, and more particularly, the present invention relates to a vaccine adjuvant composition for animals with increased stability and immunogenicity. The vaccine adjuvant according to the present invention is a W/O emulsion vaccine adjuvant, and includes a nonionic hydrophilic surfactant, nonionic lipophilic surfactant, mineral oil and/or stabilizer having an HLB value of 9 or higher. |